<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0001914'>Bleeding</z:mp> time, platelet aggregation and platelet adhesiveness were measured before and after each of 11 consecutive therapeutic sequences in 17 patients who had recently suffered a cerebro-vascular accident of atheromatous ischemic origin </plain></SENT>
<SENT sid="1" pm="."><plain>The first 10 sequences were each of 15 days duration and during the first 8 of these, aspirin was increased with each sequence from 300 mg/2 days to 3 g/day </plain></SENT>
<SENT sid="2" pm="."><plain>During the 10th sequence a placebo was given </plain></SENT>
<SENT sid="3" pm="."><plain>The final sequence (11th) lasted 3 months and during this time the dose of aspirin was fixed at 1 g/day </plain></SENT>
<SENT sid="4" pm="."><plain>Significant modification of platelet aggregation was obtained with 300 mg/2 days, platelet adhesiveness was significantly modified with 500 mg/2 days while significant <z:mp ids='MP_0001914'>bleeding</z:mp> time modification required a minimum 500 mg/day </plain></SENT>
<SENT sid="5" pm="."><plain>The results did not vary significantly with higher doses of <z:chebi fb="0" ids="15365">acetylsalicylic acid</z:chebi> (<z:chebi fb="37" ids="15365">ASA</z:chebi>) </plain></SENT>
<SENT sid="6" pm="."><plain>Only the results for the platelet aggregation were individually reproducible </plain></SENT>
<SENT sid="7" pm="."><plain>There was no statistical correlation between the results of the tests </plain></SENT>
<SENT sid="8" pm="."><plain>As far as the 3 tests are considered, the best efficiency is obtained with the therapeutic range of 500 mg to 1 g/day </plain></SENT>
</text></document>